ClinicalTrials.govpublic full text
A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111
choroideremia, nightstarx, nsr-rep1, chm, gene therapy, aav, rep1, timrepigene emparvovec, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825416
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.